Search

Influential voices in the commission and national governments want to boost spending on research and innovation from 2021 – 2028. But they are facing competing demands - and must fill a €12B Brexit-shaped hole in the coffers

Viewpoint: More EU ministers and commissioners are voicing support for bigger research and innovation funding – but the political argument is a long way from won

News analysis: Brexit planning, budget battles and the role of multinational companies are among the key issues that will dominate Brussels agendas over the next year

Viewpoint: BioMed Alliance Director Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments. In Framework Programme 9, processes must be optimised and the budget boosted - to deliver for patients and the economy

In an interview with Science|Business, Director-General Robert-Jan Smits looks forward to greater synergies for research among EU policy areas, from agriculture to development

As of January 1st, 2018 Finpro – the Finnish trade promotion organization – and Tekes – the Finnish Funding Agency for Innovation – will unite as Business Finland.

On 1st January 2018, KTH will be launching a new structure which will see five schools replacing the previous ten
 

A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.

Midlands Innovation, a group of eight universities including the University of Birmingham, has launched its plan for collaboration in technology transfer. The announcement was made at an event held at The Shard, London.

IMI’s ULTRA-DD project has made good on its promise to make its data open source with the publication online of datasets from experiments on autoimmune diseases such as lupus and myositis. ULTRA-DD hopes that if other researchers probe and use the data, they may uncover further insights that will add to our knowledge of these diseases and accelerate the development of medicines.

A Finnish blood analysis company wants to transform healthcare by unlocking health data at the molecular level.

As Estonia’s EU presidency draws to a close, the country’s education and research minister Mailis Reps talks to Science|Business about the hurdles to negotiating a bigger EU research programme and the need to rationalise the funding landscape